Kevin Panaro

5PUBLICATIONS
38CO-AUTHORS
Regenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classifiedGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 12, 2026
Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial.

|Apr 30, 2026
Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host Disease.

|Apr 20, 2026
Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial.

|Mar 30, 2026
Allogeneic transplant outcomes in T-cell prolymphocytic leukemia: a single-center retrospective study.

Mwanasha Merrill, Haesook T Kim, Amar H Kelkar

|Dec 05, 2025
Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor-risk MDS/AML.

Jacqueline S Garcia, Haesook T Kim, H Moses Murdock

Pageof 1

Frequent Collaborators

3 joint publications

Jerome Ritz

2 joint publications

Amar Kelkar

2 joint publications

Irene M Ghobrial

2 joint publications

Adam S Sperling